Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Hamadani M, Craig M, Phillips GS, Abraham J, Tse W, Cumpston A, Gibson L, Remick SC, Bunner P, Leadmon S, Elder P, Hofmeister C, Penza S, Efebera Y, Andritsos L, Garzon R, Benson DM Jr, Blum W, Devine SM. Hamadani M, et al. Among authors: gibson l. Hematol Oncol. 2011 Dec;29(4):202-10. doi: 10.1002/hon.985. Epub 2011 Feb 28. Hematol Oncol. 2011. PMID: 21360728 Free PMC article.
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation.
Kanate AS, Craig M, Cumpston A, Saad A, Hobbs G, Leadmon S, Bunner P, Watkins K, Bulian D, Gibson L, Abraham J, Remick SC, Hamadani M. Kanate AS, et al. Among authors: gibson l. Hematol Oncol Stem Cell Ther. 2011;4(4):149-56. doi: 10.5144/1658-3876.2011.149. Hematol Oncol Stem Cell Ther. 2011. PMID: 22198185 Free article.
Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation.
Awan FT, Osman S, Kochuparambil ST, Gibson L, Remick SC, Abraham J, Craig M, Jillella A, Hamadani M. Awan FT, et al. Among authors: gibson l. Bone Marrow Transplant. 2012 Jan;47(1):146-8. doi: 10.1038/bmt.2011.18. Epub 2011 Feb 28. Bone Marrow Transplant. 2012. PMID: 21358681 Clinical Trial. No abstract available.
A Scleroderma and Raynaud's UK (SRUK) national survey to explore rheumatologists' awareness, approaches to diagnosis and management and training needs within systemic sclerosis.
Blamont E, Farrington S, Glover-Southworth N, Cornwell G, Gibson L, Sloan M, Hughes M. Blamont E, et al. Among authors: gibson l. Rheumatol Adv Pract. 2024 Dec 20;9(1):rkae152. doi: 10.1093/rap/rkae152. eCollection 2025. Rheumatol Adv Pract. 2024. PMID: 39830596 Free PMC article.
Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies.
Gibson LL, Gonzalez MC, Ashton NJ, Tovar-Rios D, Blanc F, Pilotto A, Lemstra A, Paquet C, Ballard C, Zetterberg H, Aarsland D; European–Dementia With Lewy Bodies (E‐DLB) Consortium. Gibson LL, et al. Alzheimers Dement. 2024 Dec 28. doi: 10.1002/alz.14434. Online ahead of print. Alzheimers Dement. 2024. PMID: 39732510
1,327 results